SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘8-K’ for 2/27/15

On:  Friday, 2/27/15, at 9:30pm ET   ·   As of:  3/2/15   ·   For:  2/27/15   ·   Accession #:  1564590-15-1134   ·   File #:  1-35996

Previous ‘8-K’:  ‘8-K’ on / for 2/26/15   ·   Next:  ‘8-K’ on / for 3/5/15   ·   Latest:  ‘8-K’ on 4/23/24 for 4/19/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/02/15  Organovo Holdings, Inc.           8-K:7,9     2/27/15    2:52K                                    RRD ActiveDisclosure/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     16K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     18K 


8-K   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): February 27, 2015

 

ORGANOVO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Commission File Number: 001-35996

 

Delaware

 

27-1488943

(State or other jurisdiction

of incorporation)

 

(I.R.S. Employer

Identification No.)

 

6275 Nancy Ridge Dr.,

San Diego, California 92121

(Address of principal executive offices, including zip code)

 

(858) 224-1000

(Registrant’s telephone number, including area code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 


 

Item 7.01  Regulation FD Disclosure

On March 5, 2015, Keith Murphy, the President and Chief Executive Officer of Organovo Holdings, Inc. (the “Company”), will be participating in a live webcast presentation to investors via http://RetailInvestorConferences.com. During the webcast, Mr. Murphy intends to provide a business update, including an update on the commercial launch of the Company’s exVive3D Liver, Bioprinted Human Tissue and a discussion of the commercialization milestones for the Company’s 3D bioprinted kidney tissue.  The presentation will take place at 12:15 p.m. Eastern Standard Time, and investors may access the presentation at http://retailinvestorconferences.com > click on red “register / watch event now” button.

The presentation will be a live, interactive online event where investors are invited to ask questions in real-time - both in the presentation hall as well as the Company’s “virtual trade booth.” If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available at http://retailinvestorconferences.com for 90 days. A press release regarding the live webcast presentation is attached hereto as Exhibit 99.1.

The information furnished on this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall the information be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d)   Exhibits

99.1Press Release (Retail Investor Conference), dated February 27, 2015.

 

 

 

 


 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

ORGANOVO HOLDINGS, INC.

 

 

 

 

Date: March 2, 2015

/s/ Keith Murphy

 

Keith Murphy

 

Chief Executive Officer and President

 

 

 


 


 

Exhibit Index

 

Exhibit No.

 

Description

99.1

 

Press Release (Retail Investor Conference), dated February 27, 2015.

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
3/5/15
Filed as of:3/2/15
Filed on / For Period End:2/27/15S-3
 List all Filings 
Top
Filing Submission 0001564590-15-001134   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 3:27:07.2pm ET